Mitral Regurgitation Functional Clinical Trial
Official title:
Use of Percutaneous Mitral Leaflet Approach for Severe Mitral Regurgitation in Cardiogenic Shock: Results From a Multicenter Observational Italian Experience (the Mitra-Shock Study).
Cardiogenic shock (CS) is a medical emergency and a frequent cause of death. CS can be
complicated and/or precipitated by mitral regurgitation (MR). The efficacy of percutaneous
treatment of MR in patients with cardiogenic shock is unknown. The aims of the study will be
to analyse the efficacy of MitraClip therapy on early (30 days) and midterm mortality (6
months) as well as the predictors of outcomes. Investigators will also report the rate of
periprocedural complications such as minor and major bleeding, vessel injury and Acute Kidney
Injury (AKI).
It is a multicenter retrospective observational study on CE marked medical device (MitraClip®
System). Retrospective time range: from 01/01/2012 to 01/01/2020
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04147884 -
A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation
|
N/A | |
| Withdrawn |
NCT03503851 -
Noninferiority Trial of MitraClip Implantation Strategies: 1 Clip vs. 2 Clips in Patients With Functional Mitral Regurgitation
|
N/A | |
| Recruiting |
NCT04733404 -
Safety and Effectiveness Study of Dragonfly System for Functional Mitral Regurgitation
|
N/A | |
| Not yet recruiting |
NCT05846412 -
Treatment of Functional Mitral Regurgitation in Patients With Atrial Fibrillation
|
N/A |